Levamisole causes differential cytokine expression by elicited mouse peritoneal macrophages
- PMID: 1522390
- DOI: 10.1002/jlb.52.3.349
Levamisole causes differential cytokine expression by elicited mouse peritoneal macrophages
Abstract
Thioglycolate-elicited peritoneal macrophages from normal C57B1/6J mice were examined in vitro for bacterial lipopolysaccharide (LPS)-stimulated interleukin-1 (IL-1), IL-6, and tumor necrosis factor (TNF) production. Macrophages from mice administered a single oral dose of levamisole (3 mg/kg) 1 to 4 days prior to macrophage harvest demonstrated a twofold enhancement of IL-1 production compared to vehicle-treated mice. In contrast, IL-6 production and TNF production by the same macrophages were inhibited up to 36 and 62%, respectively, compared to production by macrophages harvested from vehicle-treated mice. Similar results were observed when IL-1 production and TNF production were followed in peritoneal exidate cells directly stimulated with levamisole in vitro. The ex vivo LPS-stimulated IL-1 production was enhanced 4 days after macrophage elicitation, whereas TNF and IL-6 production returned to baseline by 72 h after macrophage recruitment and augmentation. No evidence could be found for the presence of inhibitors of TNF or IL-6. The specificity of the IL-1, IL-6, and TNF bioactivities was demonstrated by neutralization with specific antisera. Immunoprecipitation studies of supernatants from biosynthetically labeled macrophages also revealed augmented IL-1 production and decreased IL-6 and TNF, indicating that levamisole may have affected cytokine production at the translational level. Kinetics studies revealed that ex vivo release of IL-6 and TNF by macrophages from levamisole-dosed mice was delayed compared to production of these cytokines by macrophages harvested from mice given vehicle only. The results may explain, in part, the reported ability of levamisole to ameliorate cases of rheumatoid arthritis or other autoimmune and inflammatory diseases by affecting the relative levels of cytokines produced by macrophages recruited to sites of injury, which are associated with inflammation and acute-phase protein synthesis.
Similar articles
-
Enhancement of in vitro lipopolysaccharide-stimulated interleukin-1 production by levamisole.Clin Immunol Immunopathol. 1991 Mar;58(3):385-98. doi: 10.1016/0090-1229(91)90129-x. Clin Immunol Immunopathol. 1991. PMID: 2001605
-
Experimental modulation of IL-1 production and cell surface molecule expression by levamisole.Ann N Y Acad Sci. 1993 Jun 23;685:259-68. doi: 10.1111/j.1749-6632.1993.tb35874.x. Ann N Y Acad Sci. 1993. PMID: 8103313 Review.
-
The immunomodulatory effects of the herbicide propanil on murine macrophage interleukin-6 and tumor necrosis factor-alpha production.Toxicol Appl Pharmacol. 1997 Jul;145(1):184-91. doi: 10.1006/taap.1997.8179. Toxicol Appl Pharmacol. 1997. PMID: 9221836
-
Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.J Immunol. 1993 May 15;150(10):4541-9. J Immunol. 1993. PMID: 8482846
-
Substance P and stress-induced changes in macrophages.Ann N Y Acad Sci. 1995 Dec 29;771:472-84. doi: 10.1111/j.1749-6632.1995.tb44703.x. Ann N Y Acad Sci. 1995. PMID: 8597423 Review.
Cited by
-
The immunomodulatory effect of levamisole is influenced by postoperative changes and type of lymphocyte stimulant.Cancer Immunol Immunother. 1995 Sep;41(3):193-8. doi: 10.1007/BF01521346. Cancer Immunol Immunother. 1995. PMID: 7553689 Free PMC article.
-
Post-operative levamisole may compromise early healing of experimental intestinal anastomoses.Br J Cancer. 1995 Aug;72(2):456-60. doi: 10.1038/bjc.1995.355. Br J Cancer. 1995. PMID: 7640232 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources